Allen Capital Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.77M | Buy |
27,685
+1,253
| +5% | +$292K | 0.61% | 40 |
|
|
2025
Q4 | $5.47M | Buy |
26,432
+612
| +2% | +$121K | 0.5% | 48 |
|
|
2025
Q3 | $4.79M | Buy |
25,820
+1,816
| +8% | +$311K | 0.45% | 54 |
|
|
2025
Q2 | $3.67M | Buy |
24,004
+1,101
| +5% | +$169K | 0.38% | 64 |
|
|
2025
Q1 | $3.8M | Buy |
22,903
+2,893
| +14% | +$453K | 0.43% | 57 |
|
|
2024
Q4 | $2.89M | Sell |
20,010
-563
| -3% | -$87.2K | 0.35% | 60 |
|
|
2024
Q3 | $3.33M | Buy |
20,573
+1,190
| +6% | +$190K | 0.41% | 54 |
|
|
2024
Q2 | $2.83M | Sell |
19,383
-3,177
| -14% | -$472K | 0.39% | 61 |
|
|
2024
Q1 | $3.57M | Buy |
22,560
+290
| +1% | +$46.2K | 0.5% | 46 |
|
|
2023
Q4 | $3.49M | Sell |
22,270
-598
| -3% | -$91.7K | 0.55% | 41 |
|
|
2023
Q3 | $3.55M | Buy |
22,868
+1,235
| +6% | +$204K | 0.63% | 36 |
|
|
2023
Q2 | $3.58M | Sell |
21,633
-59
| -0.3% | -$9.52K | 0.61% | 38 |
|
|
2023
Q1 | $3.36M | Buy |
+21,692
| New | +$3.5M | 0.61% | 37 |
|
|
2022
Q4 | – | Sell |
-19,373
| Closed | -$3.17M | – | 97 |
|
|
2022
Q3 | $3.17M | Buy |
19,373
+50
| +0.3% | +$8.46K | 0.73% | 25 |
|
|
2022
Q2 | $3.43M | Sell |
19,323
-5,329
| -22% | -$949K | 0.7% | 28 |
|
|
2022
Q1 | $4.37M | Sell |
24,652
-351
| -1% | -$59.7K | 0.83% | 23 |
|
|
2021
Q4 | $4.28M | Buy |
25,003
+18
| +0.1% | +$2.95K | 0.69% | 32 |
|
|
2021
Q3 | $4.04M | Buy |
24,985
+302
| +1% | +$51.5K | 0.81% | 27 |
|
|
2021
Q2 | $4.07M | Buy |
24,683
+3,826
| +18% | +$633K | 0.82% | 25 |
|
|
2021
Q1 | $3.43M | Buy |
20,857
+1,317
| +7% | +$213K | 0.75% | 29 |
|
|
2020
Q4 | $3.08M | Buy |
19,540
+1,289
| +7% | +$190K | 0.74% | 26 |
|
|
2020
Q3 | $2.71M | Buy |
18,251
+147
| +0.8% | +$21.8K | 0.68% | 32 |
|
|
2020
Q2 | $2.55M | Buy |
18,104
+480
| +3% | +$70K | 0.67% | 28 |
|
|
2020
Q1 | $2.31M | Sell |
17,624
-2,178
| -11% | -$309K | 0.71% | 29 |
|
|
2019
Q4 | $2.89M | Buy |
19,802
+267
| +1% | +$36.2K | 0.76% | 33 |
|
|
2019
Q3 | $2.52M | Buy |
19,535
+1,000
| +5% | +$132K | 0.78% | 31 |
|
|
2019
Q2 | $2.58M | Sell |
18,535
-4
| -0% | -$554 | 0.83% | 28 |
|
|
2019
Q1 | $2.59M | Sell |
18,539
-804
| -4% | -$108K | 0.86% | 27 |
|
|
2018
Q4 | $2.53M | Buy |
19,343
+2,032
| +12% | +$283K | 0.89% | 26 |
|
|
2018
Q3 | $2.39M | Buy |
17,311
+7,364
| +74% | +$979K | 0.79% | 34 |
|
|
2018
Q2 | $1.21M | Buy |
9,947
+1,190
| +14% | +$148K | 0.45% | 45 |
|
|
2018
Q1 | $1.12M | Buy |
8,757
+2,149
| +33% | +$290K | 0.43% | 45 |
|
|
2017
Q4 | $923K | Buy |
+6,608
| New | +$920K | 0.4% | 47 |
|
Other funds holding JNJ
VCM
VPM
Allen Capital Group's JNJ Position: Q1 2026 in Review
Allen Capital Group increased its Johnson & Johnson (JNJ) stake by 4.7% in Q1 2026, buying an estimated $292K and bringing the position to 27,685 shares worth $6.77M. The position accounts for 0.61% of the portfolio, ranked #40.
Allen Capital Group first reported a position in JNJ in Q4 2017 and has held it in 33 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Allen Capital Group held 27,685 shares of Johnson & Johnson worth $6.77M as of Q1 2026.
- Allen Capital Group bought 1,253 Johnson & Johnson shares in Q1 2026, an estimated $292K.
- Johnson & Johnson made up 0.61% of Allen Capital Group's portfolio in Q1 2026, its #40 holding.
- Allen Capital Group first reported a position in Johnson & Johnson in Q4 2017 and has held it in 33 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Allen Capital Group's 13F filing for Q1 2026, filed 27 May 2026.